These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 34834316)

  • 61. High AU content: a signature of upregulated miRNA in cardiac diseases.
    Gupta R; Soni N; Patnaik P; Sood I; Singh R; Rawal K; Rani V
    Bioinformation; 2010 Sep; 5(3):132-5. PubMed ID: 21364793
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Creating a flexible multiple microRNA expression vector by linking precursor microRNAs.
    Qiu X; Friedman JM; Liang G
    Biochem Biophys Res Commun; 2011 Jul; 411(2):276-80. PubMed ID: 21726537
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fecal MicroRNAs as Potential Biomarkers for Screening and Diagnosis of Intestinal Diseases.
    Rashid H; Hossain B; Siddiqua T; Kabir M; Noor Z; Ahmed M; Haque R
    Front Mol Biosci; 2020; 7():181. PubMed ID: 32850969
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MicroRNA-based therapeutics for cancer.
    Wang V; Wu W
    BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
    [TBL] [Abstract][Full Text] [Related]  

  • 65. miRNA: licensed to kill the messenger.
    Sen CK; Roy S
    DNA Cell Biol; 2007 Apr; 26(4):193-4. PubMed ID: 17465885
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapeutic Targeting of microRNAs in Cancer: Future Perspectives.
    Tutar L; Tutar E; Özgür A; Tutar Y
    Drug Dev Res; 2015 Nov; 76(7):382-8. PubMed ID: 26435382
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Strategies to antagonize miRNA functions in vitro and in vivo.
    Baigude H; Rana TM
    Nanomedicine (Lond); 2014 Nov; 9(16):2545-55. PubMed ID: 25490425
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Engineered RNA viral synthesis of microRNAs.
    Varble A; Chua MA; Perez JT; Manicassamy B; García-Sastre A; tenOever BR
    Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11519-24. PubMed ID: 20534531
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transgene-Like Animal Models Using Intronic MicroRNAs.
    Lin SL; Chang SE; Ying SY
    Methods Mol Biol; 2018; 1733():239-254. PubMed ID: 29435938
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Implications of RNA virus-produced miRNAs.
    Varble A; ten Oever BR
    RNA Biol; 2011; 8(2):190-4. PubMed ID: 21593582
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Current progress of miRNA-derivative nucleotide drugs: modifications, delivery systems, applications.
    Asakiya C; Zhu L; Yuhan J; Zhu L; Huang K; Xu W
    Expert Opin Drug Deliv; 2022 Apr; 19(4):435-450. PubMed ID: 35387533
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster.
    Yang X; Haurigot V; Zhou S; Luo G; Couto LB
    Hepatology; 2010 Dec; 52(6):1877-87. PubMed ID: 20931557
    [TBL] [Abstract][Full Text] [Related]  

  • 73. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.
    Bernardo BC; Ooi JY; Lin RC; McMullen JR
    Future Med Chem; 2015; 7(13):1771-92. PubMed ID: 26399457
    [TBL] [Abstract][Full Text] [Related]  

  • 74. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Integrated analysis of the miRNA-mRNA next-generation sequencing data for finding their associations in different cancer types.
    Bhowmick SS; Bhattacharjee D; Rato L
    Comput Biol Chem; 2020 Feb; 84():107152. PubMed ID: 31785969
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transgene-like animal models using intronic microRNAs.
    Lin SL; Chang SJ; Ying SY
    Methods Mol Biol; 2006; 342():321-34. PubMed ID: 16957386
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Non-viral nanocarriers for intracellular delivery of microRNA therapeutics.
    Bai Z; Wei J; Yu C; Han X; Qin X; Zhang C; Liao W; Li L; Huang W
    J Mater Chem B; 2019 Feb; 7(8):1209-1225. PubMed ID: 32255160
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Deciphering miRNAs' Action through miRNA Editing.
    Correia de Sousa M; Gjorgjieva M; Dolicka D; Sobolewski C; Foti M
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835747
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MicroRNAs in ischemia-reperfusion injury.
    Weiss JB; Eisenhardt SU; Stark GB; Bode C; Moser M; Grundmann S
    Am J Cardiovasc Dis; 2012; 2(3):237-47. PubMed ID: 22937493
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Meta-analysis of differentially-regulated hepatic microRNAs identifies candidate post-transcriptional regulation networks of intermediary metabolism in rainbow trout.
    Kostyniuk DJ; Mennigen JA
    Comp Biochem Physiol Part D Genomics Proteomics; 2020 Dec; 36():100750. PubMed ID: 33038710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.